Evidence map›Paper›PMID 31827666›Full record

ArticleOxidative medicine and cellular longevity2019

Intracellular Neuroprotective Mechanisms in Neuron-Glial Networks Mediated by Glial Cell Line-Derived Neurotrophic Factor.

Еlena V Mitroshina, Tatiana A Mishchenko, Olesya M Shirokova, Tatiana A Astrakhanova, Maria M Loginova, Ekaterina A Epifanova, Alexey A Babaev, Victor S Tarabykin, Maria V Vedunova

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Assessment of CRISPRa-mediatedFrontiers in bioengineering and biotechnology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Еlena V MitroshinaLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0003-1703-2618
Tatiana A MishchenkoLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Olesya M ShirokovaPrivolzhskiy Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod 603005, Russia.
Tatiana A AstrakhanovaLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Maria M LoginovaLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Ekaterina A EpifanovaLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Alexey A BabaevLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Victor S TarabykinLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.
Maria V VedunovaLobachevsky State University of Nizhni Novgorod, 23 Prospekt Gagarina, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0001-9759-6477
N. I. Lobachevsky State University of Nizhny Novgorod · RUPrivolzhsky Research Medical University · RUCharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has a pronounced neuroprotective effect in various nervous system pathologies, including ischaemic brain damage and neurodegenerative diseases. In this work, we studied the effect of GDNF on the ultrastructure and functional activity of neuron-glial networks during acute hypoxic exposure, a key damaging factor in numerous brain pathologies. We analysed the molecular mechanisms most likely involved in the positive effects of GDNF. Hypoxia modelling was performed on day 14 of culturing primary hippocampal cells obtained from mouse embryos (E18). GDNF (1 ng/ml) was added to the culture medium 20 min before oxygen deprivation. Acute hypoxia-induced irreversible changes in the ultrastructure of neurons and astrocytes led to the loss of functional Сa

Indexed as

AnimalsCalciumCell HypoxiaCells, CulturedCell SurvivalGlial Cell Line-Derived Neurotrophic FactorHippocampusHypoxia-Inducible Factor 1, alpha SubunitMiceMitochondriaNeuroprotective AgentsPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-retSignal TransductionCalciumGlial Cell Line-Derived Neurotrophic FactorHypoxia-Inducible Factor 1, alpha SubunitNeuroprotective AgentsPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-ret

Identifiers

PMID31827666
PMCPMC6885812
OpenAlexW2987973693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.